SolicitationActiveSPE2D2-25-R-0018
Ondansetron Orally Disintegrating Tablets
DEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY / DLA TROOP SUPPORTKey dates?
- Posted?
- Apr 8, 2026
- Response deadline?
- Apr 22, 2026, 7:00 PM UTC
- Archive date?
- —
- Archive type?
- autocustom
Classification?
- Notice type?
- Solicitation
- Base type?
- Solicitation
- Set-aside?
- —
- Set-aside code?
- —
- PSC?
- 6505
NAICS?
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE LOGISTICS AGENCY
- Office?
- DLA TROOP SUPPORT
- Office code?
- —
- Organization type?
- OFFICE
- Office address?
- PHILADELPHIA, PA, 19111, USA
Contacts?
- Nancy Fernandezprimary
- Jason C. Wraysecondary
Description?
Amendment 0004 issued since this procurement is using the procedures of 41 U.S.C. 1901, as implemented by Class Deviation 2026-O0028 – Revolutionary Federal Acquisition Regulation (FAR) Overhaul Part 12, Defense FAR Supplement (DFARS) Part 212 and Revolutionary FAR Overhaul Part 12.201-1. See updated Ondansetron ODT Solicitation attached.
Other notices in this solicitation?
- SolicitationOndansetron Orally Disintegrating TabletsMar 19, 2026
- SolicitationOndansetron Orally Disintegrating TabletsFeb 23, 2026
- SolicitationOndansetron Orally Disintegrating TabletsJan 29, 2026
- SolicitationOndansetron Orally Disintegrating TabletsJan 22, 2026
- PresolicitationOndansetron Orally Disintegrating TabletsAug 7, 2025
Similar open contracts
Metadata?
- Notice ID?
- 5bdd0ce9e9f34d9f911b37c1f9e94bc0
- Full path?
- DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
- Office code?
- —
- Ingested?
- May 2, 2026
- Updated?
- Jul 11, 2026